Hospitalization Clinical Trials

A listing of Hospitalization medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 12 clinical trials
Robot-Assisted vs Manual Transradial Cerebral Angiography (RCT)

This is a prospective, randomized controlled clinical trial designed to compare the safety and effectiveness of robot-assisted transradial cerebral angiography versus manual operation performed by experienced neurosurgeons. The study will be conducted at the Department of Neurosurgery, The First Hospital of Hebei Medical University, with a total sample size of …

  • 0 views
  • 13 Jul, 2026
Test IRB API push

To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource utilization.

  • 0 views
  • 14 Jul, 2026
Test IRB API push 2

To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource utilization.

  • 0 views
  • 14 Jul, 2026
Test 20260407-1

To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource utilization.

  • 0 views
  • 14 Jul, 2026
Clinical Outcomes and Host Immune Response in Vascular Graft and Endograft Infections (ACHIEVE)

ACHIEVE is a prospective observational cohort and biobank study of patients with suspected or diagnosed central vascular graft or endograft infection. The study also includes patients undergoing elective central vascular graft or endograft implantation and healthy blood donor controls. Participants undergo longitudinal clinical data collection and biospecimen sampling. The study …

  • 0 views
  • 13 Jul, 2026
Test IRB API push 3

To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource utilization.

  • 0 views
  • 17 Jul, 2026
  • 2 locations
New Trial POST-API-Duplicate-User1

New Trial POST-API-Duplicate-User1

  • 0 views
  • 06 Feb, 2025
Efficacy and Tolerability of a Simethicone-containing Evacuating Solution for Colorectal Cancer Screening Colonoscopy (CLEAN+)

Study to evaluate the efficacy and tolerability of a simethicone-containing evacuating solution for colorectal cancer screening colonoscopy.

  • 0 views
  • 13 Jul, 2026
Improve Postoperative Recovery by Engaging Patients and FAmily-CaregiveRs to End Delirium iPREPARED.

Behavioral intervention aimed at modifying the patient-caregiver dyad’s approach to surgical recovery to mitigate delirium risk, prevent delirium, and reduce delirium symptoms.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study (PROMISE)

The treatment decisions, assessment schedule, and study procedures in this research will adhere to the routine clinical practice of each participating center. The specifics are as follows:Treatment Decisions: Treatment will be administered in accordance with the officially approved drug label for Ivonescimab by the National Medical Products Administration (NMPA) and …

  • 0 views
  • 13 Jul, 2026